Unity Biotechnology Inc Expected To Post A Loss Of 46 Cents A Share: Earnings Preview

Unity Biotechnology

02/08/2024 12:09

* UNITY Biotechnology Inc  UBX.OQ   UBX.O  is expected
to show no
change in quarterly revenue when it reports  results on August 6
(estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for UNITY Biotechnology Inc
is for
a loss of 46 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 10.3%
in the last three months. ​
    * Wall Street's median 12-month price target for UNITY
Biotechnology Inc is $6.00​, above​ its last closing price
of $1.54. ​​​

This summary was machine generated August 2 at 11:09 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)